Effect of oxymatrine on the p38 mitogen-activated protein kinases signalling pathway in rats with CCl4 induced hepatic fibrosis

Chinese Medical Journal

Volumn 122, Issue 12, 2009, Pages 1449-1454

  Deng, Zi Yu ^a   Li, Jun ^a   Jin, Yong ^a   Chen, Xiao Liang ^a   Lü, Xiong Wen ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Liver fibrosis; Oxymatrine; p38 mitogen activated protein kinase; Signalling pathway

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; COLCHICINE; COLLAGEN; COLLAGEN TYPE 4; HYALURONIC ACID; HYDROXYPROLINE; LAMININ; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; OXYMATRINE; PHOSPHOR P38; PROCOLLAGEN; PROCOLLAGEN 3; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MECHANISM; ENZYME INHIBITION; GENE EXPRESSION; HISTOPATHOLOGY; LIVER FIBROSIS; LIVER HOMOGENATE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ACTINS; ALKALOIDS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARBON TETRACHLORIDE; COLLAGEN; COLLAGEN TYPE IV; HYALURONIC ACID; HYDROXYPROLINE; LAMININ; LIVER CIRRHOSIS; MALE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROCOLLAGEN; QUINOLIZINES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 68249154724     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.12.018     Document Type: Article

References (26)

1. Albanis E, Friedman SL. Antifibrotic agents for liver disease. Am J Transplant 2006; 6: 12-19.
2. Geerts A, Lazou JM, De Bleser P, Wisse E. Tissue distribution. quantitation and proliferation kinetics of fat storing cells in carbon tetrachloride injured rat liver. Hepatology 1991; 13: 1193-202.
3. Schmitt Graff A, Kruger S, Bochard F, Gabbiani G, Denk H. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol 1991; 138: 1233-1242.
4. Rincon M, Conze D, Weiss L, Diehl NL, Fortner KA, Yang D, et al. Conference highlight: do T cells care about the mitogen activated, protein kinase signalling pathways? Immunol Cell Biol 2000; 78: 166-175.
5. Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annu Rev Immunol 2002; 20: 55-72.
6. Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005; 15: 11-18.
7. Cao W, Medvedev AV, Daniel KW, Collins S. β adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase. J Biol Chem 2001; 276: 27077-27082.
8. Cao W, Daniel KW, Robidoux J, Puigserver P, Medvedev AV, Bai X, et al. p38 mitogen activated, protein kinase is the central regulator of cyclic AMP dependent transcription of the brown fat uncoupling protein 1 gene. Mol Cell Biol 2004; 24: 3057-3067.
9. Fan M, Rhee J, St Pierre J, Handschin C, Puigserver P, Lin J, et al. Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC 1alpha: Modulation by p38 MAPK. Genes Dev 2004; 18: 278-289.
10. Akimoto T, Pohnert SC, Li P, Zhang M, Gumbs C, Rosenberg PB, et al. Exercise stimulates PGC 1a transcription in skeletal muscle through activation of the p38 MAPK pathway. J Biol Chem 2005; 280: 19587-19593.
11. Cao WH, Collins QF, Becker TC, Robidoux J, Lupo EG Jr, Xiong Y, et al. p38 mitogen activated, protein kinase plays a stimulatory role in hepatic gluconeogenesis. J Biol Chem 2005; 280: 42731-42737.
12. Collins QF, Xiong Y, Lupo EG, Liu HY, Cao W. p38 Mitogen activated, protein kinase mediates free fatty acid induced gluconeogenesis in hepatocytes. J Biol Chem 2006; 281: 24336-24344.
13. Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, et al. The p38/ERK mitogen activated, protein kinase pathway regulates interleukin 6 synthesis response to tumor necrosis factor. EMBO J 1996; 15: 1914-1923.
14. Jiang H, Meng F, Li J, Sun X. Antiapoptosis effects of oxymatrine protect the liver from warm ischemia reperfusion injury in rats. World J Surg 2005; 29: 1397-1401
15. Liang KH, Li SB. Histological stages of chronic hepatitis, Hepatology, 2nd ed. People's Sanitary Pub, 2003: 729-731.
16. Louis H, Le Moine O, Goldman M, Deviare J. Modulation of liver injury by interleukin 10. Acta Gastroenterol Belg 2003; 66: 7-14.
17. Rockey DC. Antifibrotic therapy in chronic liver disease. Clin Gastroenterol Hepatol 2005; 3: 95-107.
18. Wu XL, Zeng WZ, Wang PL, Lei CT, Jiang MD, Chen XB, et al. Effect of compound rhodiola sachalinensis A Bor on CCl4 induced liver fibrosis in rats and its probable molecular mechanisms. World J Gastroenterol 2003; 9: 1559-1562.
19. Robinson MJ, Cobb MH. Mitogen activated, protein kinase pathways. Curr Opin Cell Biol 1997; 9: 180-186.
20. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, et al. Identification of a member of the MAPKKK family as a potential mediaytor of TGF beta signal transduction. Science 1995; 270: 2008-2011.
21. Hanafusa H, Ninomiya Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H, et al. Involvement of the p38 mitogen activated, protein kinase pathway in transforming growth factor beta induced gene expression. J Biol Chem 1999l 274: 27161-27167.
22. Wysk M, Yang DD, Lu HT, Flavell RA, Davis RJ. Requirement of mitogen activated, protein kinase kinase 3 (MKK3) for tumor necrosis factor induced cytokine expression. Proc Natl Acad Sci U S A 1999; 96: 3763-3768.
23. 2. J Biol Chem 1996; 271: 26981-26988.
24. Cao Q, Mak KM, Lieber CS. DLPC decreases TGF beta1 induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells. Am J Physiol 2002; 283: G1051-G1061.
25. Furukawa F, Matsuzaki K, Mori S, Tahashi Y, Yoshida K, Sugano Y, et al. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology 2003; 38: 879-889.
26. Luo Y, Rui HL, Chen YP. The role of MAPK/ERK1/2 signaling pathway in aldosterone stimulated transforming growth factor beta1 synthesis in renal tubular epithelial cells. Natl Med J China (Chin) 2006; 86: 3133-3137.